Retour au classement

The Clorox Company (CLX)

Sous-évalué
Consumer DefensiveHousehold & Personal ProductsUnited States

Fondamental

53

Prix

$80.03

Capitalisation boursière

$9.89B

Partie 1 · Ce que vaut l'entreprise

Vue d'ensemble

Clorox makes household staples sold under well-known names: bleach and cleaning sprays under its own Clorox brand, trash bags under Glad, charcoal under Kingsford, and personal-care and health products including Burt's Bees. It manufactures most of what it sells, ships it to large retailers, and relies on repeat, habitual purchases rather than one-off sales — a household restocks bleach or trash bags on a predictable cycle regardless of the wider economy.

Comment l'entreprise gagne de l'argent

Revenue comes from selling packaged goods to a concentrated set of large retailers, who then resell to shoppers. Margins depend on the cost of raw materials such as resin and chemicals, on manufacturing efficiency, and on holding shelf space and brand loyalty against cheaper private-label alternatives that retailers sell alongside Clorox's own products. The company reports results across four segments split by product category and by U.S. versus international markets.

Chiffre d'affaires par segment

Health and Wellness38.1%

Cleaning and disinfecting products under Clorox, plus water filtration under Brita and vitamins under Natural Vitality.

Household28.3%

Trash bags under Glad, cat litter under Fresh Step and Scoop Away, and charcoal under Kingsford.

Lifestyle18.4%

Food products including Hidden Valley dressings, and personal care through Burt's Bees.

International15.1%

The same core product categories sold outside the United States, mainly in Latin America and Canada.

Avantage concurrentiel

Marque · Étroit

Names like Clorox, Glad and Kingsford have been the default choice on U.S. shelves for generations, which lets the company hold shelf space and charge more than an unbranded equivalent. The advantage is narrow: retailer store brands compete directly in nearly every category, and a large retailer with real pricing leverage can push back hard on Clorox's terms.

Ce qui stimule la demande

Défensif

Cleaning products, trash bags and personal care items are routine, non-discretionary household purchases that people keep buying in a downturn, which makes volume relatively stable across the economic cycle. The bigger swings in results tend to come from input-cost inflation and from consumers trading down to private label when money is tight, not from skipping the purchase altogether.

Principaux risques

  • Retailer concentration — With Walmart alone worth nearly 27% of net sales, large retailers have the leverage to demand better pricing terms or to favour their own private-label products over Clorox's brands.
  • Input cost and supply chain disruption — Volatile commodity, packaging, labour, energy and logistics costs, along with the risk of supply disruption from conflicts such as those in Ukraine, the Middle East, or tensions between China and Taiwan, can raise costs faster than prices can be adjusted.
  • Cybersecurity — The company depends heavily on information technology systems and has already suffered a major cyberattack, in August 2023, that disrupted operations; a repeat incident could again halt production and shipments.
  • Private-label competition — Store-brand alternatives, often priced well below Clorox's products, compete in nearly every category the company sells in, forcing continued spending on marketing and innovation to defend market share.

Concentration des clients

Les principaux clients représentent 27% du chiffre d'affaires

Walmart and its affiliates accounted for nearly 27% of net sales in fiscal 2025, giving a single retailer significant leverage over shelf placement, promotional terms and pricing.

Les arguments en faveur

Buyers argue that Clorox's brands are habit-forming staples that hold shelf space no private label can fully dislodge, and that the company's cost-savings programme and full recovery from the 2023 cyberattack position it to grow margins even on roughly flat sales.

Les arguments contre

Sellers worry that with Walmart alone worth over a quarter of sales, Clorox has limited room to push back on retailer demands, and that persistent private-label competition plus input-cost inflation could keep squeezing volumes and margins at the same time.

Written by the editors, published on 18 août 2026

Direct competitors

Who this company fights with for the same customers

Compare

Generated on 18 septembre 2026 with claude-haiku-4-5 — shared with all users

P/E: 1127.5Score: 52Market cap: $3.12T

Reckitt's Lysol is the closest rival to Clorox's core disinfecting bleach, sprays and wipes, fighting for the same shelf space and the same household and professional cleaning budgets in North America.

P/E: 30.3Score: 69Market cap: $22.68B

Church & Dwight sells Arm & Hammer cleaning and laundry additives, cat litter and personal care to the same value-minded U.S. grocery and mass-market shopper Clorox depends on.

P/E: 21.9Score: 56Market cap: $346.41B

P&G's Mr. Clean, Swiffer, Dawn and Febreze compete directly with Clorox's home-cleaning lines for the same retail shelf and promotional slots, backed by far larger advertising and R&D budgets.

P/E: 33.7Score: 58Market cap: $68.97B

Colgate-Palmolive's home-care brands — Fabuloso, Ajax, Murphy Oil Soap — target the same surface-cleaning customer in the United States and in Clorox's Latin American markets.

S. C. Johnson & Son, Inc.Not tracked

This privately held U.S. group competes across several Clorox aisles at once: Windex and Scrubbing Bubbles against Clorox cleaners, Ziploc against Glad bags and wraps, Glade against home fragrance.

Unilever PLCNot tracked

Unilever competes with Clorox on two fronts: Domestos and Cif bleach and surface cleaners outside the U.S., and Dove, Vaseline and Simple against Burt's Bees in natural personal care.

Bilan & Liquidités

Chiffre d'affaires

$6.76B

12 derniers mois (au 31/03/2026)

Résultat net

$756M

12 derniers mois (au 31/03/2026)

Flux de trésorerie libre

$761M

Capitaux propres totaux

$321M

Passif total

$5.08B

Ratio de liquidité général

0.84

Couverture des intérêts

-

Dette/EBITDA

3.94

Bénéfice par action

Chiffre d'affaires & Résultat net

Flux de trésorerie libre

Décomposition du résultat

État historique

Marges dans le temps

La dette dans le temps

Le poids de la dette

Grille de la croissance

Croissance — Chiffre d'affaires

Estimation de la juste valeur

Cas généralSous-évalué

Juste valeur

$108.06

Prix actuel

$80.03

Marge de sécurité

+25.9%

Fourchette de juste valeur

$70.24 - $145.88

Écart entre les méthodes de valorisation utilisées, pas un intervalle de confiance calibré statistiquement.

Méthodes d'estimation

Objectif de cours des analystes:$100.76
Flux de trésorerie actualisés (DCF):$193.39
Multiple de résultat (P/E):$71.12
Formule de croissance de Graham:$35.98
Valeur de la capacité bénéficiaire (EPV):$64.12
P/B justifié:$16.85
Actualisation des dividendes (Gordon):Données insuffisantes pour le calculer
P/FFO, les fonds provenant de l'exploitation:$136.15
Bénéfices de milieu de cycle:Données insuffisantes pour le calculer
Multiple sur le chiffre d'affaires:$65.36
Consensus des analystes:Conserver (1B / 17H / 9S)
Dernière surprise sur les résultats:-0.49%

Indicateurs de valorisation

Ratio P/E

13.15

ROE

252.3%

Ratio P/B

30.81

P/FCF

25.78

Marge brute

43.8%

ROIC

-

Radar de rentabilité

Création de valeur (avantage concurrentiel)

ROIC

-

WACC

6.0%

ROIC − WACC

-

Critères d'analyse fondamentale

Réussi (12)

  • EPS shows upward trend
  • Gross Margin 43.8%
  • P/FCF 25.78
  • Positive Free Cash Flow
  • Current Ratio
  • Debt/EBITDA
  • Return on Tangible Assets
  • ROE 181.1%
  • Earnings Quality (OCF/NI) 0.76
  • Share Dilution -0.2%
  • Net Margin Trend 11.2% vs 9.9%
  • Piotroski F-Score 8/9

Échoué (11)

  • EPS CAGR 4.22%
  • Price CAGR -3.51%
  • P/B Ratio 30.81
  • Debt/Equity ratio
  • CapEx intensity
  • Low reliance on intangibles
  • Price below Graham Number
  • DCF valuation (Fairly valued)
  • Revenue Growth 5Y -1.8%
  • Analyst Consensus 4% Buy
  • Earnings Surprise avg 1.8%

Indisponible (5)

  • ROIC NaN%
  • Dividend Payout NaN%
  • Operating Margin NaN%
  • Interest Coverage
  • PEG Ratio (need PE > 0 and growth > 0)

Score F de Piotroski

8/9

Santé financière solide

score
criteria

Qualité des bénéfices

0.76

Modérée : certain écart entre profits et trésorerie

Dilution du capital

-0.2%

Rachat d'actions. Favorable aux actionnaires

Participations institutionnelles

Gouvernance

Équipe dirigeante

NomTitreÂge
Ms. Linda J. RendleCEO & Chairman47
Mr. Luc BelletExecutive VP & CFO46
Mr. Chris T. HyderExecutive VP & COO50
Ms. Nina BartonExecutive VP and Chief Growth & Strategy Officer51
Ms. Laura E. PeckVP, Chief Accounting Officer & Corporate Controller48
Ms. Chau BanksSenior VP and Chief Information & Data Officer56
Ms. Kirsten M. MarrinerExecutive VP & Chief Administrative Officer52
Ms. Lisah BurhanVice President of Investor Relations-
Ms. Angela C. HiltExecutive VP, Chief Legal & External Affairs Officer and Corporate Secretary53
Mr. Eric Sean SchwartzSenior VP & Chief Marketing Officer53

Risque d'audit

7

Risque du conseil

3

Risque de rémunération

6

Risque droits des actionnaires

8

Partie 2 · Le prix et le moment d'entrer

Cette partie ne dit pas si l'entreprise vaut la peine : elle aide à choisir quand l'acheter, une fois que les fondamentaux vous ont convaincu. À l'intérieur : analyse technique, potentiel, baisses historiques, exposition gamma.

Documents

  • Rapport annuel (10-K)

    Un aperçu annuel de l'activité, des résultats financiers et des risques de l'entreprise.

    Déposé le 2026-08-07

    Voir le document
  • Rapport trimestriel (10-Q)

    Une mise à jour de la performance financière des trois derniers mois.

    Déposé le 2026-04-30

    Voir le document
  • Rapport d'événement important (8-K)

    Un avis concernant un événement important, comme un changement de direction ou une annonce majeure.

    Déposé le 2026-08-03

    Voir le document

via SEC EDGAR

Historique des résultats

via SEC EDGAR

Latest News

Recent headlines for CLX, sourced from Markets Gazette.

  • 8/3/2026POSITIVE
    Clorox Expects Full-Year Sales Boost From Purell Deal

    The Clorox Company announced fiscal fourth-quarter earnings that surpassed analyst forecasts, signaling resilience despite challenges. While sales volumes were down and the recent acquisition of GOJO Industries, the maker of Purell, incurred additional logistics costs, the overall financial performance indicates effective management. The company anticipates a full-year sales boost stemming from the Purell integration, suggesting a positive outlook for future revenue streams. Investors will be watching the successful integration of GOJO and its impact on Clorox's market position and profitability in the coming quarters.

via Markets Gazette